Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

GLG News by Medical Device Experts

Anthony Catanach, Director

Anthony CatanachDirectorDI2 Associates, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

More Under Armour Red Flags...

November 20, 2009

Stock Jocks Punish Under Armour's Mathletes | www.cnbc.com

Under Armour's most recent 10K contains a number of financial reporting "red flags" that reflect a cavalier attitude toward financial reporting transparency.

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Will Quest Acquire Vermillion?

November 20, 2009

Why Quest Will Acquire Vermillion | www.genomeweb.com

Quest Diagnostics has had a known relationship with Vermillion.  Now that Vermillion has received FDA approval for its OVA1 in vitro diagnostic multi-variant index assay (IVDMIA) and Quest has an exclusive three year marketing license and a 17% investment in the company plus additional loans, acquisition of Vermillion could make sense for both companies.

Anthony Catanach, Director

Anthony CatanachDirectorDI2 Associates, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

What the Former SEC Chairmen Missed...

November 19, 2009

Don't Let Banks Hide Bad Assets | online.wsj.com

Conceptually, the arguments favoring fair value accounting are sound and quite appealing. Unquestionably, financial statement users will benefit from data about how a company’s assets and liabilities change in value during a reporting period. However, there are two major issues associated with fair value reporting that accountants, investors, legislators, and regulators need to address in the wake of our most recent financial crisis.

Anthony Catanach, Director

Anthony CatanachDirectorDI2 Associates, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

What Have the Accountants Done For Us Lately?

November 19, 2009

Systemic risk legislation threatens FASB’s independence | www.accountingweb.com

Debates about the causes of the recent financial crisis have yet to focus on the inability of financial institution independent auditors to provide adequate oversight over management’s valuations of financial instruments.

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Roche Receives H1N1 FDA Emergency Use Authorization

November 16, 2009

Roche Gets FDA EUA for H1N1 Test Kit | www.genomeweb.com

Roche has received an Emergency Use Authorization from the FDA for its RealTime ready Influenza A/H1N1 Detection Set.  The new H1N1 assay is run on its MagNA Pure LC platform for nucleic acid isolation and its LightCycler 2.0 system for real-time PCR applications.  Roche, the worldwide clinical diagnostics leader should have an advantage in the H1N1 market segment.

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Sequenom Sued by Shareholders

November 14, 2009

Sequenom Shareholders Sue Company, Officials over SEQureDx Data Mishandling | www.genomeweb.com

The Sequenom sage appears endless.  Following the "mishandling of data" involving the company's Down's syndrome test, termination of company executives, investigation by the NASDAQ , the SEC and the US Attorney for the Southern District of California, Xenomics lawsuit against Sequenom seeking up to $300 million in damages, Sequenom shareholders have filed a suit against the company and several individual current and former executives .  The news continues to mount and none of it is good.

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Epigenomics Reports Excellent 3Q Returns

November 12, 2009

Epigenomics Nearly Quadruples Sales in Q3 | www.genomeweb.com

Germany based Epigenomics posted stellar Q3 financial results and reduced net loss by 8%.  According to the company, the increase comes from existing collaborations, new partnerships, and license agreements

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

New Sample Prep Company

November 12, 2009

Life Technologies to Buy Biotrove, Which Will Form Mass Spec Sample Prep Company | www.biotrove.com

Following on Life Technologies' (NASDAQ: LIFE) acquisition of Biotrove, Biotrove announced in a separate release that it will form a subsidiary for a sample handing company for mass spectroscopy systems.  This could be the real opportunity for future growth.

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Consolidation Continues in Life Sciences

November 11, 2009

Qiagen Acquires SABiosciences for $90M | www.genomeweb.com

Qiagen (NASDAQ: GQEN) has entered into a definitive agreement to acquire privately held SABiosciences for $90 million dollars.  Meanwhile, Life Technologies has entered into a definitive agreement to acquire, the manufacturer of the OpenArray high-throughput gene expression and genotyping system.  Yesterday's announcements are more examples of the high level of consolidation activity occurring in the wide open life sciences space.

Ken Powell, President

Ken PowellPresidentGenesis Business Development, LLC What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Quest Diagnostics to Offer New Colorectal Cancer Test

November 9, 2009

Quest to Offer Septin9 Colorectal Cancer LTD 'Later This Year' | www.genomeweb.com

Quest Diagnostics senior spokesperson Jay Wohlgemuth said that Quest plans to launch a new Laboratory Developed Test (LDT) for colorectal cancer based on Epigenomics’ mSEPT9 DNA-methylation biomarker.  Many companies have searched for a blood-based marker as an effective diagnostic alternative to colonoscopy, which would encourage the 90 million adults over 50 to be screened for colorectal cancer.

Page : 12345678910Next1 to 10 of 293

Leading institutions connect with members of the Healthcare councils through GLG

Most Popular Healthcare News